[INTESTINAL FAILURE AND YERSINIA PSEUDOTUBERCULOSIS TRANSLOCATION IN THE DEVELOPMENTOF EXPERIMENTAL GENERALIZED

Abstract

Insights

Probiotic lactobacilli metabolites prevent generalized pseudotuberculosis infection in mice by maintaining intestinal barrier function and exhibiting antimicrobial effects against Yersinia pseudotuberculosis. This highlights a novel therapeutic strategy for bacterial infections.

Area of Science:

  • Microbiology
  • Pathology
  • Immunology

Context:

  • Experimental pseudotuberculosis in conventional white mice was studied to understand the role of intestinal failure and bacterial translocation.
  • The study investigated the pathological manifestations of Yersinia pseudotuberculosis infection in response to bacterial adhesion and colonization.

Purpose:

  • To determine the role of intestinal failure, bacterial translocation, and normal intestinal microbiota in the initiation and generalization of experimental pseudotuberculosis.
  • To evaluate the pathological manifestations as a response to pathogen adhesion and colonization.

Summary:

  • Oral administration of supernatant fluid from Lactobacillus plantarum 8P-A3, containing microbial metabolites, prevented generalized pseudotuberculosis and reduced pathomorphological changes in mice.
  • Both the probiotic supernatant and gentamicin administration equally inhibited the development of severe infection and tissue damage.

Impact:

  • Metabolites of L. plantarum 8P-A3 effectively control pseudotuberculosis development by preserving intestinal colonization resistance and exerting antimicrobial effects.
  • This research suggests a potential therapeutic application of probiotic-derived metabolites in managing bacterial infections and preventing pathogen translocation.